AU2001283817A1 - A dough composition comprising a lipid-encapsulated enzyme - Google Patents

A dough composition comprising a lipid-encapsulated enzyme

Info

Publication number
AU2001283817A1
AU2001283817A1 AU2001283817A AU8381701A AU2001283817A1 AU 2001283817 A1 AU2001283817 A1 AU 2001283817A1 AU 2001283817 A AU2001283817 A AU 2001283817A AU 8381701 A AU8381701 A AU 8381701A AU 2001283817 A1 AU2001283817 A1 AU 2001283817A1
Authority
AU
Australia
Prior art keywords
lipid
dough composition
encapsulated enzyme
encapsulated
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283817A
Inventor
Gitte Budolfsen
Thomas Honger Callisen
Claus Crone Fuglsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of AU2001283817A1 publication Critical patent/AU2001283817A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01032—Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A23L7/107—Addition or treatment with enzymes not combined with fermentation with microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • General Preparation And Processing Of Foods (AREA)
AU2001283817A 2000-09-08 2001-09-07 A dough composition comprising a lipid-encapsulated enzyme Abandoned AU2001283817A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001339 2000-09-08
DKPA200001339 2000-09-08
PCT/DK2001/000583 WO2002019828A1 (en) 2000-09-08 2001-09-07 A dough composition comprising a lipid-encapsulated enzyme

Publications (1)

Publication Number Publication Date
AU2001283817A1 true AU2001283817A1 (en) 2002-03-22

Family

ID=8159702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283817A Abandoned AU2001283817A1 (en) 2000-09-08 2001-09-07 A dough composition comprising a lipid-encapsulated enzyme

Country Status (2)

Country Link
AU (1) AU2001283817A1 (en)
WO (1) WO2002019828A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US6764699B2 (en) * 2000-12-05 2004-07-20 Roberto Gonzalez Barrera Corn tortillas with improved texture retention using an enzyme blend in nixtamalized corn flour
CA2490944C (en) * 2002-07-03 2012-05-15 Novozymes A/S Treatment of dough with a lipoxygenase and a lipolytic enzyme
CN1681392B (en) * 2002-09-11 2010-06-09 普瑞图斯股份有限公司 Use of family 8 enzymes with xylan lytic activity in baking
EP1413202A1 (en) * 2002-10-22 2004-04-28 CSM Nederland B.V. Lipid-encapsulated functional bakery ingredients
US6835397B2 (en) 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
WO2005084446A1 (en) * 2004-03-04 2005-09-15 Csm Nederland B.V. Granulate containing a functional food ingredient and method for the manufacture thereof
EP1586240A1 (en) * 2004-03-31 2005-10-19 LESAFFRE et Cie Bread improver
EP2669002A1 (en) * 2005-01-28 2013-12-04 Japan Science and Technology Agency Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
WO2006138305A2 (en) * 2005-06-16 2006-12-28 Novozymes North America, Inc. Method and use of a laccase enzyme in a baked product
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
GB0600913D0 (en) 2006-01-17 2006-02-22 Syngenta Ltd Improvements in or relating to organic compounds
EP2103219A1 (en) * 2008-03-10 2009-09-23 Novozymes A/S Dough with fructan and fructan-degrading enzyme
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
KR20170005192A (en) 2009-01-06 2017-01-11 큐어론 엘엘씨 Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
KR101694931B1 (en) 2009-01-06 2017-01-10 큐어론 엘엘씨 Compositions and methods for the treatment or the prevention oral infections by e. coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
DK2595488T3 (en) * 2010-07-21 2020-02-24 Novozymes As PROCEDURE FOR THE PREPARATION OF A BAKED PRODUCT WITH ANTILLING AMYLASE AND PEPTIDASE
CN106310242B (en) 2011-04-21 2020-02-28 柯尔马克有限责任公司 Compounds for the treatment of neuropsychiatric disorders
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
CN107771884A (en) * 2017-12-09 2018-03-09 宁夏和谐富硒食品高科技有限公司 A kind of making of thick multigrain biscuit of selenium-rich nutritive and its production method
DK4142501T3 (en) * 2020-04-30 2024-04-15 Dupont Nutrition Biosci Aps INGREDIENT SYSTEM FOR BAKERY PRODUCTS
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032336A2 (en) * 1997-01-22 1998-07-30 Kerry Ingredients (Uk) Limited Enzyme-based bread improvers
WO1998038869A1 (en) * 1997-03-03 1998-09-11 Danisco A/S Edible food improving composition with deferred activity
JPH11113479A (en) * 1997-07-22 1999-04-27 Gist Brocades Nv New food additive composition for bread
AU8797998A (en) * 1997-08-20 1999-03-08 Danisco A/S Compositions containing encapsulated food additive and their use
EP1889904A3 (en) * 1999-10-01 2008-07-09 Novozymes A/S Enzyme granulate

Also Published As

Publication number Publication date
WO2002019828A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001283817A1 (en) A dough composition comprising a lipid-encapsulated enzyme
AU2001267333A1 (en) Lipolytic enzyme
AU2001269836A1 (en) Proteases
AU2001284934A1 (en) Steroid derived antibiotics
AU2002357860A1 (en) Enzymes
AU1878601A (en) Enzyme
AU2002224922A1 (en) Liquid yeast compositions
AU2001288121A1 (en) Enzyme electrode
AU2001227900A1 (en) Drug metabolizing enzymes
AU2001274981A1 (en) Drug metabolizing enzymes
AU2001270303A1 (en) Drug metabolizing enzymes
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU2001264247A1 (en) GASC1 gene
AU2001247483A1 (en) Proteases
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001237592A1 (en) Enzymes and uses relating thereto
AU2001284047A1 (en) Butinol I esterase
AU2001255324A1 (en) Drug metabolizing enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2001292330A1 (en) Drying-resistant yeast
AU2001285743A1 (en) Adipose-related gene
AU2285701A (en) Proteases
AU2001278154A1 (en) Drug metabolizing enzymes
AU4620300A (en) Can
AU4367900A (en) Carbohydrate-modifying enzymes